{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:15:55Z","timestamp":1784657755126,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-1-I2M-030"],"award-info":[{"award-number":["2021-1-I2M-030"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32141003"],"award-info":[{"award-number":["32141003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.phymed.2024.155400","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:48:10Z","timestamp":1706806090000},"page":"155400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Discovery of Gambogic acid as an antibacterial adjuvant against vancomycin-resistant enterococci in vitro and in vivo"],"prefix":"10.1016","volume":"128","author":[{"given":"Jing","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-4566","authenticated-orcid":false,"given":"Xi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9124-071X","authenticated-orcid":false,"given":"Yanxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefu","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155400_bib0001","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the Enterococcus: beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.phymed.2024.155400_bib0002","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.155400_bib0003","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejmech.2018.04.059","article-title":"New developments in non-quinolone-based antibiotics for the inhibition of bacterial gyrase and topoisomerase IV","volume":"152","author":"Badshah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2024.155400_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/id500013t","article-title":"A new-class antibacterial-almost. Lessons in drug discovery and development: a critical analysis of more than 50 years of effort toward ATPase inhibitors of DNA gyrase and topoisomerase IV","volume":"1","author":"Bisacchi","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.phymed.2024.155400_bib0005","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.45.2001628","article-title":"Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020","volume":"26","author":"Brinkwirth","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.phymed.2024.155400_bib0006","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-resistant enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.phymed.2024.155400_bib0007","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.bmcl.2016.05.030","article-title":"Caged xanthones: Potent inhibitors of global predominant MRSA USA300","volume":"26","author":"Chaiyakunvat","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2024.155400_bib0008","series-title":"Methods For Determining Bactericidal Activity of Antimicrobial Agents","year":"1999"},{"key":"10.1016\/j.phymed.2024.155400_bib0009","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2021"},{"key":"10.1016\/j.phymed.2024.155400_bib0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phymed.2024.155400_bib0011","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/JB.187.4.1536-1540.2005","article-title":"Contribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniae","volume":"187","author":"Dupont","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.phymed.2024.155400_bib0012","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ph16020261","article-title":"Developments in Non-Intercalating bacterial topoisomerase inhibitors: allosteric and ATPase inhibitors of DNA gyrase and topoisomerase IV","volume":"16","author":"Grossman","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phymed.2024.155400_bib0013","doi-asserted-by":"crossref","first-page":"12268","DOI":"10.1038\/s41598-018-30756-4","article-title":"Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients","volume":"8","author":"Hamed","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155400_bib0014","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"key":"10.1016\/j.phymed.2024.155400_bib0015","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3389\/fphar.2019.00986","article-title":"Transcriptional analysis of the effects of gambogic acid and neogambogic acid on methicillin-resistant staphylococcus aureus","volume":"10","author":"Hua","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155400_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104266","article-title":"Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors","volume":"104","author":"Jaswal","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phymed.2024.155400_bib0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-4781(98)00126-2","article-title":"DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities","volume":"1400","author":"Levine","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2024.155400_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1045291","article-title":"Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid","volume":"13","author":"Li","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.phymed.2024.155400_bib0019","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1021\/cb5001197","article-title":"Structures of kibdelomycin bound to Staphylococcus aureus GyrB and ParE showed a novel U-shaped binding mode","volume":"19","author":"Lu","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.phymed.2024.155400_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","article-title":"Vancomycin-resistant enterococcal infections","volume":"e342","author":"Murray","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2024.155400_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phymed.2024.155400_bib0022","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.phymed.2024.155400_bib0023","first-page":"143","article-title":"Antifungal combinations","volume":"118","author":"Vitale","year":"2005"},{"key":"10.1016\/j.phymed.2024.155400_bib0024","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2174\/187152012802650066","article-title":"Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis","volume":"12","author":"Wang","year":"2012","journal-title":"AntiCancer Agents Med. Chem."},{"key":"10.1016\/j.phymed.2024.155400_bib0025","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.phymed.2024.155400_bib0026","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2024.155400_bib0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.canlet.2012.03.004","article-title":"Gambogenic acid induces G1 arrest via GSK3\u03b2-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells","volume":"322","author":"Yu","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.155400_bib0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.taap.2016.09.003","article-title":"Neogambogic acid prevents silica-induced fibrosis via inhibition of high-mobility group box 1 and MCP-1-induced protein 1","volume":"309","author":"Zhang","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155400_bib0029","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4065\/81.4.529","article-title":"Vancomycin-resistant enterococci: colonization, infection, detection, and treatment","volume":"81","author":"Zirakzadeh","year":"2006","journal-title":"Mayo Clin. Proc."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T15:17:07Z","timestamp":1724080627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"alternative-id":["S0944711324000655"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155400","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Gambogic acid as an antibacterial adjuvant against vancomycin-resistant enterococci in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155400"}}